At a glance
Metech International Limited, an SGX Catalist-listed investment holding company specializing in environmental technology and health supplements
The company achieved a financial turnaround, returning to a net profit of S$348,000 from a previous net loss of S$394,000
During the first half of the financial year 2026, with financial positions recorded as of 30 June 2026
Operations were anchored within the health supplement market in China, under the regulatory oversight of the Singapore Exchange
Higher gross margins and increased non-operating building management income drove profitability. However, uncollected trade receivables triggered severe working capital depletion
Management mitigated an extreme S$11,000 cash shortfall by utilizing employee loans. They subsequently secured private placements and interest-free loan facilities
Metech International Returns to Profitability While Walking a Cash Tightrope
Metech International Limited delivered an operational turnaround in the first half of 2026, returning to net profitability despite severe underlying liquidity constraints. The Catalist-listed investment holding company reported a net profit attributable to shareholders of S$348,000** for HY2026, recovering from a net loss of **S$394,000 in HY2025. However, this accounting recovery was achieved on an extraordinarily thin liquidity reserve. Cash and cash equivalents stood at a precarious S$11,000 as of 30 June 2026, keeping Singapore Exchange (SGX) regulatory oversight active and necessitating ongoing quarterly interim disclosures due to going concern uncertainties.
Top Financial Takeaways
The financial metrics for HY2026 reflect a notable structural expansion in top-line profitability, set against significant working capital stress.
| Financial Metric | HY2026 | HY2025 / Comparative | Growth / Change |
| Revenue | S$3,210,000 | S$3,061,000 | +4.87% |
| Gross Profit | S$605,000 | S$338,000 | +78.99% |
| Gross Margin | 18.85% | 11.04% | +7.81 percentage points |
| Net Profit / (Loss) Attributable to Owners | S$348,000 | (S$394,000) | Turnaround |
| Net Cash Used in Operating Activities | (S$1,185,000) | (S$2,143,000) | -44.70% (Reduced cash burn) |
| Cash and Cash Equivalents | S$11,000 (as of 30/06/2026) | S$198,000 (as of 31/12/2025) | -94.44% |
| NAV per Share | 0.55 cents (as of 30/06/2026) | (0.21) cents (as of 31/12/2025) | Turnaround |
A detailed examination reveals a critical disconnect between reported earnings and actual cash generation. Although net profit reached S$348,000 and gross margin widened to 18.85%, operating cash flow remained deeply negative at -S$1,185,000. This disparity stems from a severe working capital drag, as paper gains were absorbed by a S$3.50 million surge in trade receivables, which expanded from S1.42 million as of 31 December 2025 to S$4.92 million by 30 June 2026. Uncollected sales locked up vital operational liquidity. Furthermore, evaluating the quality of earnings shows that “Other Income” surged to S$366,000 (up from S$6,000 in HY2025), driven primarily by non-operating building management income of S$357,000. In effect, non-operating building management fees accounted for virtually all of the reported net profit attributable to shareholders.
Health Supplements Drive 100% of Revenue
Metech’s top-line performance is fully anchored by its Health Supplements Business. During HY2026, the entire S$3.21 million in Group revenue originated exclusively from this division within the People’s Republic of China. Segment profitability strengthened from S355,000 in HY2025 to S$598,000 in HY2026.
However, total reliance on a single product line and geographic territory presents substantial concentration risks. Out of total Group assets of S$6.40 million as of 30 June 2026, S4.70 million (73.4%) is concentrated inside the Health Supplements division. To leverage this engine while expanding market depth, management is utilizing a newly acquired health supplement license held by its supplier to broaden sales outreach across China while co-investing in supplier factory upgrades and equipment.
Despite segment growth, total working capital depletion maintains severe going concern risk. The statutory audit statement from the interim report outlines this structural vulnerability:
“Notwithstanding that the Group was in a net current asset position as at 30 June 2026, the Group’s low cash balance, net cash used in operating activities, and the Company’s net current liabilities and net liabilities position indicate the existence of a material uncertainty which may cast significant doubt on the Group’s and the Company’s ability to continue as going concerns.”
Post Period Capital Raised Buys Vital Runway
To bridge the extreme cash shortfall of S$11,000 recorded at the end of June 2026, Metech relied on temporary solvency measures before executing post-period capital initiatives. During HY2026, the Group drew down S$982,000 in short-term employee loans, pushing total employee loan liabilities to S$1,009,000 as of 30 June 2026 to fund daily operational expenditures.
Subsequent to the reporting period, management executed major funding moves:
- Private Placement: On 30 July 2026, the Company completed a partial issuance of 72 million new ordinary shares (out of a planned 100 million share placement) to Mr. Ma Ong Kee and Raffles Capital Limited, generating S$2.856 million in net cash proceeds and leaving room for prospective further issuance.
- New Loan Facility: On 6 August 2026, Metech contracted a new S$3.0 million interest-free loan from high-net-worth supporter Mr. Cao Shixuan.
- Existing Debt Structure: The Company maintains approximately S$460,000 in undrawn funds under an earlier S$3.0 million interest-free facility from Mr. Cao established in October 2024. This existing facility faces an immediate debt maturity on 23 September 2026, with S$2.5 million of the principal already settled.
While these liquidity injections offer temporary operational runway, they highlight a persistent reliance on external financing and cause ownership per share compression. Total issued ordinary shares grew from 201,010,200 at year-end 2025 to 263,510,200 as of 30 June 2026, with additional share expansion resulting from the July placement.
Pivot Away From Diamonds Toward Biomass and Food Valorization
Metech is actively redirecting capital from legacy non-core assets toward agritech and green technology ventures.
As part of this realignment, shareholders formally approved the divestment of the Group’s 80% equity interest in lab-grown diamond manufacturer Asian Eco Technology Pte. Ltd. to Wuhan Xilu Trading Co., Ltd. on 30 April 2026.
In the agritech sector, Metech’s biomass carbon reduction system machines completed factory testing and commissioning. Partnering with Colorful Paradise Agricultural Cooperation Co., Ltd. (CPAC) in Taiwan, the initiative secured government grant approval, leading to initial machine orders and active planning for broader ASEAN deployment.
Concurrently, Metech signed a non-binding memorandum of understanding with MLF Ingredients Sdn. Bhd. to manufacture high-protein animal nutrition products. The target formulation combines 40% protein derived from food valorization streams (soy waste, dairy waste, and brewer’s extract residues) with 60% plant-based inputs. Third-party laboratory testing has validated the nutritional composition, and management is evaluating commercialization across South Korea, the United States, Europe, and Asia, using Malaysia as a primary production hub.
What Investors Must Watch Next
Metech International presents a dual operational profile: expanding gross margins set against fragile working capital health. Investors following the stock must monitor key operational catalysts against balance sheet risks.
Upside Catalysts to Watch
- Conversion of gross margin expansion (18.85%) into positive cash generation.
- Inflow of S$2.856 million in net placement proceeds to restore cash reserves.
- Continued backing from interest-free loan providers to support liquidity.
- Commercial monetization of government-supported biomass technology in Taiwan and regional animal nutrition rollout.
Downside Risks to Monitor
- Operational cash burn, which absorbed S$1.185 million in HY2026.
- Working capital tie-up from trade receivables rising to S$4.92 million.
- Near-term maturity on 23 September 2026 for the remaining October 2024 interest-free loan balance.
- One hundred percent revenue concentration within China’s health supplement market.
- Continued ownership per share compression resulting from dilutive equity issuances.
Related stories: Union Steel FY2026 Results Reveal Strategic Shifts Amid Profit Pressures